| First Author | Nishino T | Year | 2022 |
| Journal | Biochem Biophys Res Commun | Volume | 628 |
| Pages | 91-97 | PubMed ID | 36084556 |
| Mgi Jnum | J:332460 | Mgi Id | MGI:7343321 |
| Doi | 10.1016/j.bbrc.2022.08.058 | Citation | Nishino T, et al. (2022) GAREM1 is involved in controlling body mass in mice and humans. Biochem Biophys Res Commun 628:91-97 |
| abstractText | The adaptor protein GAREM has two subtypes. Each is involved in Erk activation signaling downstream of the cell growth factor receptor in cultured cells. Regarding their role in individual animals, we have previously reported that mice deficient in GAREM2, which is highly expressed in the brain, exhibit emotional changes. In this paper, we report an amino acid substitution mutation (K291R) in GAREM1, in a patient with idiopathic short stature, which indicates that the mutant exhibits dominant-negative properties. The GAREM K291R mutant did not promote Erk activation in EGF-stimulated cultured cells. Similar features were also observed in cells in which GAREM1 expression was suppressed by genome editing; along with Erk, phosphorylation of S6 kinase and 4EBP1, whose activation is necessary for cell proliferation and biological growth, were inhibited Furthermore, we generated mice deficient in GAREM1 and showed that the mutant mice are lighter in weight. Overall, the results of this paper suggest that GAREM1 is required for normal growth and for maintaing average body size in humans and mice. |
